AI-generated summary
The authors report a prospective split-face trial in 10 Chinese adults with moderate facial photoaging, treating one side of the face with a 755nm picosecond alexandrite laser with a diffractive lens array over four sessions. Blinded dermatologists rated improvement, with the treated side showing a mean global photoaging score decrease from 2.67 to 1.44 at two months, and the authors describe the treatment as efficacious and safe.
- Participants
- 10
- Who or what was studied
- Ten Chinese adults with moderate facial photoaging
- Wavelengths
- 755 nm
- Limits stated in the abstract
- The study enrolled only 10 subjects, had no randomized or independent control group beyond the untreated side of the face, and reported short-term follow-up of two months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 755nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.